# Ezetimibe for Arrhythmia Recurrence After AF Ablation

> **NCT07752758** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Second Affiliated Hospital, Zhejiang University, School of Medicine** · enrollment: 120 (estimated)

## Conditions studied

- Atrial Fibrillation
- Post-Catheter Ablation Atrial Arrhythmia Recurrence

## Interventions

- **DRUG:** Ezetimibe
- **OTHER:** Standardized post-ablation clinical management

## Key facts

- **NCT ID:** NCT07752758
- **Lead sponsor:** Second Affiliated Hospital, Zhejiang University, School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-15
- **Primary completion:** 2028-06-01
- **Final completion:** 2028-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07752758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07752758, "Ezetimibe for Arrhythmia Recurrence After AF Ablation". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07752758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*